Wall Street Zen cut shares of Modular Medical (NASDAQ:MODD – Free Report) to a strong sell rating in a research report sent to investors on Saturday morning.
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Modular Medical in a research note on Wednesday, June 24th. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Modular Medical currently has a consensus rating of “Sell”.
Read Our Latest Research Report on Modular Medical
Modular Medical Stock Performance
Modular Medical (NASDAQ:MODD – Get Free Report) last announced its quarterly earnings results on Friday, August 14th. The company reported ($1.19) earnings per share (EPS) for the quarter.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of MODD. 683 Capital Management LLC raised its position in Modular Medical by 79.4% in the 4th quarter. 683 Capital Management LLC now owns 1,762,103 shares of the company’s stock worth $642,000 after purchasing an additional 780,000 shares during the period. Bleichroeder LP lifted its stake in Modular Medical by 41.9% in the fourth quarter. Bleichroeder LP now owns 2,859,581 shares of the company’s stock worth $1,041,000 after purchasing an additional 845,000 shares during the last quarter. Jane Street Group LLC boosted its position in shares of Modular Medical by 446.8% during the fourth quarter. Jane Street Group LLC now owns 163,952 shares of the company’s stock valued at $60,000 after buying an additional 133,969 shares during the period. Perritt Capital Management Inc boosted its position in shares of Modular Medical by 34.2% during the third quarter. Perritt Capital Management Inc now owns 85,000 shares of the company’s stock valued at $59,000 after buying an additional 21,675 shares during the period. Finally, AWM Investment Company Inc. grew its stake in shares of Modular Medical by 20.3% during the second quarter. AWM Investment Company Inc. now owns 441,095 shares of the company’s stock valued at $1,985,000 after buying an additional 74,429 shares during the last quarter. Institutional investors own 27.47% of the company’s stock.
About Modular Medical
Modular Medical, Inc operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.
See Also
- Five stocks we like better than Modular Medical
- Is Best Buy the AI Winner Hiding in the Electronics Aisle?
- Applied Materials Beat Everything but Wall Street’s Expectations for Margins
- Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
- Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.
